Skip to main content
SpringerLink
Log in

Surgical Treatment of Heart Failure

  • Chapter
Advanced Imaging In Coronary Artery Disease

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 202))

  • 122 Accesses

Abstract

Heart failure is defined as cardiac pumping dysfunction with circulatory and neurohormonal responses and develops as a consequence of cardiac disease1. Ischemic heart disease accounts for more than 60% of all cases with heart failure. In a substantial number of cases the aetiology is unknown and the term idiopathic cardiomyopathy is used. The importance of valvular disease and hypertension as a cause of heart failure has declined steadily2. Heart failure has become one of the most prevalent cardiovascular disorders and represents a significant clinical and financial burden in the Western World 3. The prevalence is expected to increase further, predominantly due to aging of the population, higher survival rates after acute myocardial infarction and longer survival of persons with heart disease. Furthermore, simulation models predict a transition from acute to chronic cardiovascular disease due to a significant increase in age adjusted ischemic heart disease in the Netherlands by 2010, that is largely attributable to heart failure 4. The prevalence in the general population ranges from 1.0 to 5.0 individuals per 1000 with a steep increase to 30 to 130 individuals per 1000 for those aged over 65 years5,6. Between 1980 and 1992, the annual number of hospital admissions in the Netherlands increased almost by 70%, and in 1989 the health care costs were Dfl 436 million or 1% of the national health care budget6. In the US it is estimated that 3 million individuals are afflicted by heart failure and nearly 500,000 new cases are diagnosed each year. In 1989 the associated health care cost were more than $8 billion 7.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Dutch heart failure consensus meeting 1994. Hart Bull 1994; 25:254–304.

    Google Scholar 

  2. Ghali JK, Kay R, Shelton B, et al. Contemporary etiologies of left ventricular dysfunction and/or heart failure and their influence on prognosis [abstract]. Circulation 1992:86(4 suppl 1):I598.

    Google Scholar 

  3. Kannel WB. Epidemiology and prevention of cardiac failure: Framingham Study insights.Eur Heart J 1987; 8 Suppl F: 23–6.

    Google Scholar 

  4. Bonneux L, Barendregt JJ, Meeter K, Bonsel GJ, van der Maas PJ. Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure. Am J Public Health 1994; 84:20–8.

    Google Scholar 

  5. Lamberts H, Brouwer HJ, Mohrs J. Reason for encounter-, episode-and process-oriented standard output: from the Transition Project. Amsterdam: Department. General Practice/Family Medicine, University of Amsterdam, 1991.

    Google Scholar 

  6. Van de Lisdonk EH, van den Bosch WJHM, Huygen FJA, Lagro-Jansen ALM, editors. Ziekten in de huisartspraktijk. Utrecht: Bunge, 1990.

    Google Scholar 

  7. Mosterd A. Epidemiology of heart failure. [dissertation]. Utrecht: S.N., 1997.

    Google Scholar 

  8. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993; 88:107–15.

    Article  PubMed  CAS  Google Scholar 

  9. Koopmanschap MA, van Roijen L, Bonneux L. Kosten van ziekten in Nederland. Herz. ed. Rotterdam: Instituut Maatschappelijke Gezondheidszorg, Erasmus Universiteit Rotterdam, 1991.

    Google Scholar 

  10. Sarris GE, Moore KA, Schroeder JS, et al. Cardiac transplantation: the Stanford experience in the cyclosporine era. J Thorac Cardiovasc Surg 1994; 108:240–52.

    PubMed  CAS  Google Scholar 

  11. Stevenson LW, Hamilton MA, Tillisch IH, et al. Decreasing survival benefit from cardiac transplantation for outpatients as the waiting list lengthens. J Am Coll Cardiol 1991; 18:919–25.

    Article  PubMed  CAS  Google Scholar 

  12. Brouwer MH, Bams JL, Van den Berg MP, Van Veldhuisen DJ, Ebels T. Succesvolle harttransplantatie bij langdurige beademde patiënten. Ned Tijdschr Geneeskd 1996; 140:2353–5.

    PubMed  CAS  Google Scholar 

  13. Carpentier A, Chachques JC, Acar C, et al. Dynamic cardiomyoplasty at seven years. J Thorac Cardiovasc Surg 1993; 106:42–54.

    PubMed  CAS  Google Scholar 

  14. Carpentier A, Chachques JC, Carteaux JP. Dynamic cardiomyoplasty at eleven years. In: Carpentier A, Chachques JC, Grandjean P, editors: Cardiac bioassist. New York: Futura, 1997:3–23.

    Google Scholar 

  15. Batista RJ, Santos JL, Takeshita N, Bochinno L, Lima PN, Cunha MA. Partial left ventriculectomy to improve left ventricular function in end-stage heart disease [published erratum appears in J Card Surg 1997; 12:ix]. J Card Surg 1996; 11:96–8.

    Article  PubMed  CAS  Google Scholar 

  16. Salmons S, Jarvis JC. Skeletal muscle as an adaptive contractile biomaterial for cardiac assistance: fundamental considerations. Proceedings of the 14th Annual Conference of the IEEE Engineering in Medicine and Biology Society, Paris, France, 1992, 2798–9.

    Google Scholar 

  17. Salmons S, Sreter FA. Significance of impulse activity in the transformation of skeletal muscle type. Nature 1976; 263:30–4.

    Article  PubMed  CAS  Google Scholar 

  18. Moreira LF, Bocchi EA, Stolf NAG, Bellotti G, Jatene AD. Long-term results of cardiomyoplasty in dilated cardiomyopathy. In: Carpentier A, Chachques JC, Grandjean P, editors. Cardiac bioassist. New York: Futura, 1997:25–35.

    Google Scholar 

  19. Van den Berg MP, Brouwer MH, Wijnberg DS, Brügemann J, Van der Maaten JM, Ebels T. De eerste Groningse ervaringen met dynamische cardiomyoplastiek. Ned Tijdschr Geneeskd 1997; 141:1480–4.

    Google Scholar 

  20. Odim JN, Burgess JH, Chiu RC. Range of responses to dynamic cardiomyoplasty in dilated cardiomyopathy patients. In: Carpentier A, Chachques JC, Grandjean P, editors. Cardiac bioassist. New York: Futura, 1997:97–108.

    Google Scholar 

  21. Lee KF, Dignan RJ, Parmar JM, et al. Effects of dynamic cardiomyoplasty on left ventricular performance and myocardial mechanics in dilated cardiomyopathy. J Thorac Cardiovasc Surg 1991; 102:124–31.

    PubMed  CAS  Google Scholar 

  22. Salmons S, Jarvis JC. Cardiomyoplasty: a look at the fundamentals. In: Carpentier A, Chachques JC, Grandjean PA, editors. Cardiomyoplasty. Mount Kisco, New York: Futura, 1991:3–17.

    Google Scholar 

  23. Lorusso R, Sandrelli L, Borghetti V, Schreuder J, Alfieri O. Longterm myocardial assistance by a wrapped skeletal muscle. A clinical experience. In: Carpentier A, Chachques JC, Grandjean P, editors. Cardiac bioassist. New York: Futura, 1997:57–65.

    Google Scholar 

  24. Schelbert HR, Phelps ME, Huang SC, et al. N-13 ammonia as an indicator of myocardial blood flow. Circulation 1981; 63:1259–72.

    Article  PubMed  CAS  Google Scholar 

  25. Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron emission tomography. N Engl J Med 1986; 314:884–8.

    Article  PubMed  CAS  Google Scholar 

  26. Buxton DB, Nienaber CA, Luxen A,et al. Noninvasive quantification of regional myocardial oxygen consumption in vivo with (1-11C) acetate and dynamic positron emission tomography. Circulation 1989; 79:134–42.

    Article  PubMed  CAS  Google Scholar 

  27. Gambhir SS, Schwaiger M, Huan SC, et al. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. J Nucl Med 1989; 30:359–66.

    PubMed  CAS  Google Scholar 

  28. Furnary AP, Magovern JA, Christlieb IY, Orie JE, Simpson KA, Magovern GJ. Clinical cardiomyoplasty: preoperative factors associated with outcome. Ann Thorac Surg 1992; 54:1139–43.

    Article  PubMed  CAS  Google Scholar 

  29. Corin WJ, George DT, Sink JD, Santamore WP. Dynamic cardiomyoplasty acutely impairs left ventricular diastolic function. J Thorac Cardiovasc Surg 1992; 104:1662–71.

    PubMed  CAS  Google Scholar 

  30. Medtronic Cardiomyoplasty Phase I Study Group. Phase I Clinical results through October 1991, prepared by Medtronic CAS Venture, April 1992.

    Google Scholar 

  31. McCarthy M. Batista procedure proves its value in the USA. Lancet 1997; 349:855.

    Article  Google Scholar 

  32. Angelini GD, Prynn S, Mehta D, et al. Left ventricular-volume reduction for end-stage heart failure [letter]. Lancet 1997; 350:489.

    Article  PubMed  CAS  Google Scholar 

  33. Dickstein ML, Spotnitz HM, Rose EA, Burkhoff D. Heart reduction surgery: an analysis of the impact on cardiac function. J Thorac Cardiovasc Surg 1997; 113:1032–40.

    Article  PubMed  CAS  Google Scholar 

  34. Batista RJ, Verde J, Nery P, et al. Partial left ventriculectomy to treat end-stage heart disease. Ann Thorac Surg 1997; 64:634–8.

    Article  PubMed  CAS  Google Scholar 

  35. Baldy C, Douek P, Croisille P, Magnin IE, Revel D, Amiel M. Automated myocardial edge detection from breath-hold-cine MR images: Evaluation of left ventricular volumes and mass. Magn Reson Imaging 1994; 12:589.

    Article  PubMed  CAS  Google Scholar 

  36. Cranney GB, Lotan CS, Dean L, Baxley W, Bouchard A, Pohost GM. Left ventricular volume measurement using cardiac axis nuclear magnetic resonance imaging. Validating by calibrated ventricular angiography. Circulation 1990; 82:154–63.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. René M. H. J. Brouwer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maarten P. van den Berg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eduard L. Mooyaard
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Cardiology, Leiden University Medical Center Leiden, Leiden, The Netherlands

    Ernst E. Van Der Wall

  2. Department of Cardiology, University Hospital Groningen, Groningen, The Netherlands

    Paul K. Blanksma  & Harry J. G. M. Crijns  & 

  3. Department of Cardiology, Martini Hospital, Groningen, The Netherlands

    Menco G. Niemeyer

  4. PET-center, University Hospital Groningen, Groningen, The Netherlands

    Willem Vaalburg

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Brouwer, R.M.H.J., van den Berg, M.P., Mooyaard, E.L. (1998). Surgical Treatment of Heart Failure. In: Van Der Wall, E.E., Blanksma, P.K., Niemeyer, M.G., Vaalburg, W., Crijns, H.J.G.M. (eds) Advanced Imaging In Coronary Artery Disease. Developments in Cardiovascular Medicine, vol 202. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-0866-2_20

Download citation

  • DOI: https://doi.org/10.1007/978-94-007-0866-2_20

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-3746-4

  • Online ISBN: 978-94-007-0866-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation